FoxP1 Represses MEF2A in Striated Muscle

References

• Frontera WR, Ochala J. Skeletal muscle: a brief review of structure and function. Calcif Tissue Int. 2015;96:183–195. doi:10.1007/s00223-014-9915-y.
   PubMed Web of Science ®Google Scholar
• Hernández-Hernández JM, García-González EG, Brun CE, Rudnicki MA. The myogenic regulatory factors, determinants of muscle development, cell identity and regeneration. Semin Cell Dev Biol. 2017;72:10–18. doi:10.1016/j.semcdb.2017.11.010.
   PubMed Web of Science ®Google Scholar
• Taylor MV, Hughes SM. Mef2 and the skeletal muscle differentiation program. Semin Cell Dev Biol. 2017;72:33–44. doi:10.1016/j.semcdb.2017.11.020.
   PubMed Web of Science ®Google Scholar
• Medrano JL, Naya FJ. The transcription factor MEF2A fine-tunes gene expression in the atrial and ventricular chambers of the adult heart. J Biol Chem. 2017;292:20975–20988. doi:10.1074/jbc.M117.806422.
   PubMed Web of Science ®Google Scholar
• Wong TWY, Ahmed A, Yang G, Maino E, Steiman S, Hyatt E, Chan P, Lindsay K, Wong N, Others GD. A novel mouse model of Duchenne muscular dystrophy carrying a multi-exonic Dmd deletion exhibits progressive muscular dystrophy and early-onset cardiomyopathy. Dis Model Mech. 2020;13(9):dmm045369.
   Web of Science ®Google Scholar
• Wu W, Huang X, Cheng J, Li Z, de Folter S, Huang Z, Jiang X, Pang H, Tao S. Conservation and evolution in and among SRF- and MEF2-type MADS domains and their binding sites. Mol Biol Evol. 2011;28:501–511. doi:10.1093/molbev/msq214.
   PubMed Web of Science ®Google Scholar
• Cornwell JD, McDermott JC. MEF2 in cardiac hypertrophy in response to hypertension. Trends Cardiovasc Med. 2023;33:204–212. doi:10.1016/j.tcm.2022.01.002.
   PubMed Web of Science ®Google Scholar
• Potthoff MJ, Olson EN. MEF2: a central regulator of diverse developmental programs. Development. 2007;134:4131–4140. doi:10.1242/dev.008367.
   PubMed Web of Science ®Google Scholar
• Lu J, McKinsey TA, Zhang CL, Olson EN. Regulation of skeletal myogenesis by association of the MEF2 transcription factor with class II histone deacetylases. Mol Cell. 2000;6:233–244. doi:10.1016/s1097-2765(00)00025-3.
   PubMed Web of Science ®Google Scholar
• Quinn ZA, Yang CC, Wrana JL, McDermott JC. Smad proteins function as co-modulators for MEF2 transcriptional regulatory proteins. Nucleic Acids Res. 2001;29:732–742. doi:10.1093/nar/29.3.732.
   PubMed Web of Science ®Google Scholar
• Mao Z, Bonni A, Xia F, Nadal-Vicens M, Greenberg ME. Neuronal activity-dependent cell survival mediated by transcription factor MEF2. Science. 1999;286:785–790. doi:10.1126/science.286.5440.785.
   PubMed Web of Science ®Google Scholar
• Kolodziejczyk SM, Wang L, Balazsi K, DeRepentigny Y, Kothary R, Megeney LA. MEF2 is upregulated during cardiac hypertrophy and is required for normal post-natal growth of the myocardium. Curr Biol. 1999;9:1203–1206. doi:10.1016/S0960-9822(00)80027-5.
   PubMed Web of Science ®Google Scholar
• Youn HD, Sun L, Prywes R, Liu JO. Apoptosis of T cells mediated by Ca2+-induced release of the transcription factor MEF2. Science. 1999;286:790–793. doi:10.1126/science.286.5440.790.
   PubMed Web of Science ®Google Scholar
• Blaeser F, Ho N, Prywes R, Chatila TA. Ca(2+)-dependent gene expression mediated by MEF2 transcription factors. J Biol Chem. 2000;275:197–209. doi:10.1074/jbc.275.1.197.
   PubMed Web of Science ®Google Scholar
• Frey N, Olson EN. Cardiac hypertrophy: the good, the bad, and the ugly. Annu Rev Physiol. 2003;65:45–79. doi:10.1146/annurev.physiol.65.092101.142243.
   PubMed Web of Science ®Google Scholar
• Wiedmann M, Wang X, Tang X, Han M, Li M, Mao Z. PI3K/Akt-dependent regulation of the transcription factor myocyte enhancer factor-2 in insulin-like growth factor-1- and membrane depolarization-mediated survival of cerebellar granule neurons. J Neurosci Res. 2005;81:226–234. doi:10.1002/jnr.20556.
   PubMed Web of Science ®Google Scholar
• Liu N, Nelson BR, Bezprozvannaya S, Shelton JM, Richardson JA, Bassel-Duby R, Olson EN. Requirement of MEF2A, C, and D for skeletal muscle regeneration. Proc Natl Acad Sci USA. 2014;111:4109–4114. doi:10.1073/pnas.1401732111.
   PubMed Web of Science ®Google Scholar
• Dumont NA, Bentzinger CF, Sincennes MC, Rudnicki MA. Satellite cells and skeletal muscle regeneration. Compr Physiol. 2015;5:1027–1059. doi:10.1002/cphy.c140068.
   PubMed Web of Science ®Google Scholar
• Hashemi S, Salma J, Wales S, McDermott JC. Pro-survival function of MEF2 in cardiomyocytes is enhanced by beta-blockers. Cell Death Discov. 2015;1:15019. doi:10.1038/cddiscovery.2015.19.
   PubMed Web of Science ®Google Scholar
• Akazawa H, Komuro I. Roles of cardiac transcription factors in cardiac hypertrophy. Circ Res. 2003;92:1079–1088. doi:10.1161/01.RES.0000072977.86706.23.
   PubMed Web of Science ®Google Scholar
• Neyroud D, Nosacka RL, Callaway CS, Trevino JG, Hu H, Judge SM, Judge AR. FoxP1 is a transcriptional repressor associated with cancer cachexia that induces skeletal muscle wasting and weakness. J Cachexia Sarcopenia Muscle. 2021;12:421–442. doi:10.1002/jcsm.12666.
   PubMed Web of Science ®Google Scholar
• Rothbauer U, Zolghadr K, Muyldermans S, Schepers A, Cardoso MC, Leonhardt H. A versatile nanotrap for biochemical and functional studies with fluorescent fusion proteins. Mol Cell Proteomics. 2008;7:282–289. doi:10.1074/mcp.M700342-MCP200.
   PubMed Web of Science ®Google Scholar
• Wang B, Weidenfeld J, Lu MM, Maika S, Kuziel WA, Morrisey EE, Tucker PW. Foxp1 regulates cardiac outflow tract, endocardial cushion morphogenesis and myocyte proliferation and maturation. Development. 2004;131:4477–4487. doi:10.1242/dev.01287.
   PubMed Web of Science ®Google Scholar
• Moustafa A, Hashemi S, Brar G, Grigull J, Ng SHS, Williams D, Schmitt-Ulms G, McDermott JC. The MEF2A transcription factor interactome in cardiomyocytes. Cell Death Dis. 2023;14:240. doi:10.1038/s41419-023-05665-8.
   PubMed Web of Science ®Google Scholar
• Mughal W, Nguyen L, Pustylnik S, da Silva Rosa SC, Piotrowski S, Chapman D, Du M, Alli NS, Grigull J, Halayko AJ, et al. A conserved MADS-box phosphorylation motif regulates differentiation and mitochondrial function in skeletal, cardiac, and smooth muscle cells. Cell Death Dis. 2015;6:e1944. doi:10.1038/cddis.2015.306.
   PubMed Web of Science ®Google Scholar
• Bai S, Kerppola TK. Opposing roles of FoxP1 and Nfat3 in transcriptional control of cardiomyocyte hypertrophy. Mol Cell Biol. 2011;31:3068–3080. doi:10.1128/MCB.00925-10.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Li S, Yuan L, Tian Y, Weidenfeld J, Yang J, Liu F, Chokas AL, Morrisey EE. Foxp1 coordinates cardiomyocyte proliferation through both cell-autonomous and nonautonomous mechanisms. Genes Dev. 2010;24:1746–1757. doi:10.1101/gad.1929210.
   PubMed Web of Science ®Google Scholar
• Jiang X, Ji S, Yuan F, Li T, Cui S, Wang W, Ye X, Wang R, Chen Y, Zhu S. Pyruvate dehydrogenase B regulates myogenic differentiation via the FoxP1-Arih2 axis. J Cachexia Sarcopenia Muscle. 2023;14:606–621. doi:10.1002/jcsm.13166.
   PubMed Web of Science ®Google Scholar
• Lozano R, Gbekie C, Siper PM, Srivastava S, Saland JM, Sethuram S, Tang L, Drapeau E, Frank Y, Buxbaum JD. FOXP1 syndrome: a review of the literature and practice parameters for medical assessment and monitoring. J Neurodev Disord. 2021;13:18.
   PubMed Web of Science ®Google Scholar
• Rocca DL, Wilkinson KA, Henley JM. SUMOylation of FOXP1 regulates transcriptional repression via CtBP1 to drive dendritic morphogenesis. Sci Rep. 2017;7:877. doi:10.1038/s41598-017-00707-6.
   PubMed Web of Science ®Google Scholar
• Gordon JW, Pagiatakis C, Salma J, Du M, Andreucci JJ, Zhao J, Hou G, Perry RL, Dan Q, Courtman D, and others., et al. Protein kinase A-regulated assembly of a MEF2{middle dot}HDAC4 repressor complex controls c-Jun expression in vascular smooth muscle cells. J Biol Chem. 2009;284:19027–19042. doi:10.1074/jbc.M109.000539.
   PubMed Web of Science ®Google Scholar
• Majidi SP, Reddy NC, Moore MJ, Chen H, Yamada T, Andzelm MM, Cherry TJ, Hu LS, Greenberg ME, Bonni A. Chromatin environment and cellular context specify compensatory activity of paralogous MEF2 transcription factors. Cell Rep. 2019;29:2001–2015.e5. doi:10.1016/j.celrep.2019.10.033.
   PubMed Web of Science ®Google Scholar
• Naya FJ, Olson E. MEF2: a transcriptional target for signaling pathways controlling skeletal muscle growth and differentiation. Curr Opin Cell Biol. 1999;11:683–688. doi:10.1016/s0955-0674(99)00036-8.
   PubMed Web of Science ®Google Scholar
• Jang M, Scheffold J, Røst LM, Cheon H, Bruheim P. Serum-free cultures of C2C12 cells show different muscle phenotypes which can be estimated by metabolic profiling. Sci Rep. 2022;12:827. doi:10.1038/s41598-022-04804-z.
   PubMed Web of Science ®Google Scholar
• Schöneich C, Dremina E, Galeva N, Sharov V. Apoptosis in differentiating C2C12 muscle cells selectively targets Bcl-2-deficient myotubes. Apoptosis. 2014;19:42–57. doi:10.1007/s10495-013-0922-7.
   PubMed Web of Science ®Google Scholar
• Myer A, Olson EN, Klein WH. MyoD cannot compensate for the absence of myogenin during skeletal muscle differentiation in murine embryonic stem cells. Dev Biol. 2001;229:340–350. doi:10.1006/dbio.2000.9985.
   PubMed Web of Science ®Google Scholar
• Tripathi S, Miyake T, McDermott JC. Smad7:beta-catenin complex regulates myogenic gene transcription. Cell Death Dis. 2019;10:387. doi:10.1038/s41419-019-1615-0.
   PubMed Web of Science ®Google Scholar
• Andrés V, Walsh K. Myogenin expression, cell cycle withdrawal, and phenotypic differentiation are temporally separable events that precede cell fusion upon myogenesis. J Cell Biol. 1996;132:657–666. doi:10.1083/jcb.132.4.657.
   PubMed Web of Science ®Google Scholar
• Cserjesi P, Olson EN. Myogenin induces the myocyte-specific enhancer binding factor MEF-2 independently of other muscle-specific gene products. Mol Cell Biol. 1991;11:4854–4862. doi:10.1128/mcb.11.10.4854-4862.1991.
   PubMed Web of Science ®Google Scholar
• Nakatsuji Y, Hidaka K, Tsujino S, Yamamoto Y, Mukai T, Yanagihara T, Kishimoto T, Sakoda S. A single MEF-2 site is a major positive regulatory element required for transcription of the muscle-specific subunit of the human phosphoglycerate mutase gene in skeletal and cardiac muscle cells. Mol Cell Biol. 1992;12:4384–4390.
   PubMed Web of Science ®Google Scholar
• Edmondson DG, Cheng TC, Cserjesi P, Chakraborty T, Olson EN. Analysis of the myogenin promoter reveals an indirect pathway for positive autoregulation mediated by the muscle-specific enhancer factor MEF-2. Mol Cell Biol. 1992;12:3665–3677. doi:10.1128/mcb.12.9.3665-3677.1992.
   PubMed Web of Science ®Google Scholar
• Buchberger A, Ragge K, Arnold HH. The myogenin gene is activated during myocyte differentiation by pre-existing, not newly synthesized transcription factor MEF-2. J Biol Chem. 1994;269:17289–17296.
   PubMed Web of Science ®Google Scholar
• Jayathilaka N, Han A, Gaffney KJ, Dey R, Jarusiewicz JA, Noridomi K, Philips MA, Lei X, He J, Ye J, and others., et al. Inhibition of the function of class IIa HDACs by blocking their interaction with MEF2. Nucleic Acids Res. 2012;40:5378–5388. doi:10.1093/nar/gks189.
   PubMed Web of Science ®Google Scholar
• Zhao X, Sternsdorf T, Bolger TA, Evans RM, Yao TP. Regulation of MEF2 by histone deacetylase 4- and SIRT1 deacetylase-mediated lysine modifications. Mol Cell Biol. 2005;25:8456–8464. doi:10.1128/MCB.25.19.8456-8464.2005.
   PubMed Web of Science ®Google Scholar
• Ornatsky OI, Cox DM, Tangirala P, Andreucci JJ, Quinn ZA, Wrana JL, Prywes R, Yu YT, McDermott JC. Post-translational control of the MEF2A transcriptional regulatory protein. Nucleic Acids Res. 1999;27:2646–2654. doi:10.1093/nar/27.13.2646.
   PubMed Web of Science ®Google Scholar
• Perry RLS, Yang C, Soora N, Salma J, Marback M, Naghibi L, Ilyas H, Chan J, Gordon JW, McDermott JC. Direct interaction between myocyte enhancer factor 2 (MEF2) and protein phosphatase 1α represses MEF2-dependent gene expression. Mol Cell Biol. 2009;29:3355–3366. doi:10.1128/MCB.00227-08.
   PubMed Web of Science ®Google Scholar
• Cox DM, Du M, Marback M, Yang EC, Chan J, Siu KW, McDermott JC. Phosphorylation motifs regulating the stability and function of myocyte enhancer factor 2A. J Biol Chem. 2003;278:15297–15303. doi:10.1074/jbc.M211312200.
   PubMedGoogle Scholar
• Barsyte-Lovejoy D, Galanis A, Sharrocks AD. Specificity determinants in MAPK signaling to transcription factors. J Biol Chem. 2002;277:9896–9903. doi:10.1074/jbc.M108145200.
   PubMed Web of Science ®Google Scholar
• de Angelis L, Zhao J, Andreucci JJ, Olson EN, Cossu G, McDermott JC. Regulation of vertebrate myotome development by the p38 MAP kinase-MEF2 signaling pathway. Dev Biol. 2005;283:171–179. doi:10.1016/j.ydbio.2005.04.009.
   PubMed Web of Science ®Google Scholar
• Dionyssiou MG, Nowacki NB, Hashemi S, Zhao J, Kerr A, Tsushima RG, McDermott JC. Cross-talk between glycogen synthase kinase 3beta (GSK3beta) and p38MAPK regulates myocyte enhancer factor 2 (MEF2) activity in skeletal and cardiac muscle. J Mol Cell Cardiol. 2013;54:35–44. doi:10.1016/j.yjmcc.2012.10.013.
   PubMed Web of Science ®Google Scholar
• Zhao M, New L, Kravchenko VV, Kato Y, Gram H, di Padova F, Olson EN, Ulevitch RJ, Han J. Regulation of the MEF2 family of transcription factors by p38. Mol Cell Biol. 1999;19:21–30. doi:10.1128/MCB.19.1.21.
   PubMed Web of Science ®Google Scholar
• Puri PL, Wu Z, Zhang P, Wood LD, Bhakta KS, Han J, Feramisco JR, Karin M, Wang JY. Induction of terminal differentiation by constitutive activation of p38 MAP kinase in human rhabdomyosarcoma cells. Genes Dev. 2000;14:574–584. doi:10.1101/gad.14.5.574.
   PubMed Web of Science ®Google Scholar
• Ikeda S, He A, Kong SW, Lu J, Bejar R, Bodyak N, Lee K-H, Ma Q, Kang PM, Golub TR, et al. MicroRNA-1 negatively regulates expression of the hypertrophy-associated calmodulin and Mef2a genes. Mol Cell Biol. 2009;29:2193–2204. doi:10.1128/MCB.01222-08.
   PubMed Web of Science ®Google Scholar
• Clerk A, Michael A, Sugden PH. Stimulation of the p38 mitogen-activated protein kinase pathway in neonatal rat ventricular myocytes by the G protein-coupled receptor agonists, endothelin-1 and phenylephrine: a role in cardiac myocyte hypertrophy? J Cell Biol. 1998;142:523–535. doi:10.1083/jcb.142.2.523.
   PubMed Web of Science ®Google Scholar
• Moretti I, Ciciliot S, Dyar KA, Abraham R, Murgia M, Agatea L, Akimoto T, Bicciato S, Forcato M, Pierre P, et al. MRF4 negatively regulates adult skeletal muscle growth by repressing MEF2 activity. Nat Commun. 2016;7:12397. doi:10.1038/ncomms12397.
   PubMed Web of Science ®Google Scholar
• Sassoon D, Lyons G, Wright WE, Lin V, Lassar A, Weintraub H, Buckingham M. Expression of two myogenic regulatory factors myogenin and MyoD1 during mouse embryogenesis. Nature. 1989;341:303–307. doi:10.1038/341303a0.
   PubMed Web of Science ®Google Scholar
• Wright WE, Sassoon DA, Lin VK. Myogenin, a factor regulating myogenesis, has a domain homologous to MyoD. Cell. 1989;56:607–617. doi:10.1016/0092-8674(89)90583-7.
   PubMed Web of Science ®Google Scholar
• Chang CI, Xu BE, Akella R, Cobb MH, Goldsmith EJ. Crystal structures of MAP kinase p38 complexed to the docking sites on its nuclear substrate MEF2A and activator MKK3b. Mol Cell. 2002;9:1241–1249. doi:10.1016/s1097-2765(02)00525-7.
   PubMed Web of Science ®Google Scholar
• Liu ML, Olson AL, Edgington NP, Moye-Rowley WS, Pessin JE. Myocyte enhancer factor 2 (MEF2) binding site is essential for C2C12 myotube-specific expression of the rat GLUT4/muscle-adipose facilitative glucose transporter gene. J Biol Chem. 1994;269:28514–28521. doi:10.1016/S0021-9258(18)46957-8.
   PubMed Web of Science ®Google Scholar
• Longo PA, Kavran JM, Kim MS, Leahy DJ. Transient mammalian cell transfection with polyethylenimine (PEI). Methods Enzymol. 2013;529:227–240. doi:10.1016/B978-0-12-418687-3.00018-5.
   PubMed Web of Science ®Google Scholar
• Miyake T, Aziz A, McDermott JC. Maintenance of the undifferentiated state in myogenic progenitor cells by TGFbeta signaling is Smad independent and requires MEK activation. Int J Mol Sci. 2020;21(3):1057. doi: 10.3390/ijms21031057.
   Web of Science ®Google Scholar
• Perez-Riverol Y, Bai J, Bandla C, García-Seisdedos D, Hewapathirana S, Kamatchinathan S, Kundu DJ, Prakash A, Frericks-Zipper A, Eisenacher M, et al. The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences. Nucleic Acids Res. 2022;50:D543–D552. doi:10.1093/nar/gkab1038.
   PubMed Web of Science ®Google Scholar